BPC-157 is described in the literature as a stable gastric pentadecapeptide, and reviews discuss its preclinical activity in gastrointestinal injury, cytoprotection, intestinal anastomosis, fistula, and inflammatory injury models (Multifunctionality and Possible Medical Application of the BPC 157 Peptide, Gastroenterology Research and Practice)
Statistics Mice were randomly distributed in groups of 6 animals per cage prior to start experimental procedures
These can include temporary swelling, bruising, redness or tenderness in the treated areas
When using observational or lower level interventional data, the ASIPP grading requires several studies in order to provide a rating
Thus, this study has shown that pentadecapeptide BPC 157 counteracts morphine-induced analgesia